These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33843425)

  • 21. Epigenetics in Alzheimer's Disease: A Critical Overview.
    Villa C; Combi R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's Disease and Histone Code Alterations.
    Narayan P; Dragunow M
    Adv Exp Med Biol; 2017; 978():321-336. PubMed ID: 28523554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease.
    Bryzgalov LO; Korbolina EE; Merkulova TI
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic drugs in Alzheimer's disease.
    Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
    Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?
    Fischer A
    Neuropharmacology; 2014 May; 80():95-102. PubMed ID: 24486385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetically regulated microRNAs in Alzheimer's disease.
    Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
    Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response.
    Cacabelos R; Torrellas C
    Int J Mol Sci; 2015 Dec; 16(12):30483-543. PubMed ID: 26703582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Modifications and Alzheimer's Disease.
    Smith RG; Lunnon K
    Adv Exp Med Biol; 2017; 978():303-319. PubMed ID: 28523553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of epigenetic modifications in neurodegenerative diseases.
    Qu W; Zhuang Y; Li X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):642-650. PubMed ID: 34986527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
    Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
    Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroepigenetics and Alzheimer's Disease: An Update.
    Zusso M; Barbierato M; Facci L; Skaper SD; Giusti P
    J Alzheimers Dis; 2018; 64(3):671-688. PubMed ID: 29991138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic nutraceutical diets in Alzheimer's disease.
    Davinelli S; Calabrese V; Zella D; Scapagnini G
    J Nutr Health Aging; 2014 Nov; 18(9):800-5. PubMed ID: 25389957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease.
    Fetahu IS; Ma D; Rabidou K; Argueta C; Smith M; Liu H; Wu F; Shi YG
    Sci Adv; 2019 Aug; 5(8):eaaw2880. PubMed ID: 31489368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease.
    Signal B; Pérez Suárez TG; Taberlay PC; Woodhouse A
    Neurobiol Dis; 2023 Oct; 186():106284. PubMed ID: 37683959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic mechanisms in Alzheimer's disease.
    Daniilidou M; Koutroumani M; Tsolaki M
    Curr Med Chem; 2011; 18(12):1751-6. PubMed ID: 21466476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic modifications in Alzheimer's disease: cause or effect?
    Piaceri I; Raspanti B; Tedde A; Bagnoli S; Sorbi S; Nacmias B
    J Alzheimers Dis; 2015; 43(4):1169-73. PubMed ID: 25159670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
    Chatterjee P; Roy D; Rathi N
    J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenome-wide association studies in Alzheimer's disease; achievements and challenges.
    van den Hove DLA; Riemens RJM; Koulousakis P; Pishva E
    Brain Pathol; 2020 Sep; 30(5):978-983. PubMed ID: 32654262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.
    Roubroeks JAY; Smith RG; van den Hove DLA; Lunnon K
    J Neurochem; 2017 Oct; 143(2):158-170. PubMed ID: 28805248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.
    Adwan L; Zawia NH
    Pharmacol Ther; 2013 Jul; 139(1):41-50. PubMed ID: 23562602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.